Patent Assignment
Reel/Frame 074050/0682
Intellectual Property Security Agreement
Recorded: 2025-12-23
Pages: 14
Assignor
BAUSCH + LOMB IRELAND LIMITED
Executed: 2025-12-18
Assignee
CITIBANK, N.A., AS NOTES COLLATERAL AGENT
388 GREENWICH STREET, NEW YORK, NEW YORK, 10013
Covered Properties
(37)
Compositions and Methods for Treatment of Eye Disorders
Quinazolinone Derivatives Useful as Vanilloid Antagonists
Crystalline Pharmaceutical and Methods of Preparation and Use Thereof
Compositions and Methods for Treatment of Eye Disorders
Quinazolinone Derivatives Useful as Vanilloid Antagonists
Crystalline Pharmaceutical and Methods of Preparation and Use Thereof
Compositions and Methods for Treatment
PAT058652-Us-Cnt
Compositions and Methods for Treatment of Eye Disorders
Crystalline Pharmaceutical and Methods of Preparation and Use Thereof
Crystalline Pharmaceutical and Methods of Preparation and Use Thereof
Lfa-1 Inhibitor and Methods of Preparation and Polymorph Thereof
Compositions and Methods for Treatment
Crystalline Pharmaceutical and Methods of Preparation and Use Thereof
Crystalline Pharmaceutical and Methods of Preparation and Use Thereof
Lfa-1 Inhibitor Formulations
Compositions and Methods for Treatment of Diabetic Retinopathy
Lfa-1 Inhibitor and Methods of Preparation and Polymorph Thereof
Continuous Flow Carboxylation Reaction
Crystalline Pharmaceutical and Methods of Preparation and Use Thereof
Crystalline Pharmaceutical and Methods of Preparation and Use Thereof
Lfa-1 Inhibitor and Methods of Preparation and Polymorph Thereof
Continuous Flow Carboxylation Reaction
Lfa-1 Inhibitor and Methods of Preparation and Polymorph Thereof
Continuous Flow Carboxylation Reaction
Formulations of 4-(7-Hydroxy-2-isopropyl-4-oxo-4H-quinazolin-3-yl)-benzonitrile
Fractionated Topical Ocular Drug Delivery Methods and Devices for Use in the Same
Patent:
12,496,218 →
Application:
17/096,348 →
Methods for Treating Ocular Surface Pain
Crystalline Forms of 4-(7-Hydroxy-2-Isopropyl-4-Oxo-4H-Quinazolin-3-Yl)-Benzonitrile and Formulations Thereof
Application:
17/430,819 →
Publication:
US 2022/0162170
1,3-Substituted Cyclobutyl Derivatives and Uses Thereof
Compositions and Methods for Treatment
Crystalline Forms of 4-(7-Hydroxy-2-Isopropyl-4-Oxo-4H-Quinazolin-3-Yl)-Benzonitrile and Formulations Thereof
Semifluorinated Alkane Antibiotic Combination Compositions for Treatment of Ocular Disorders
Application:
19/130,485 →
Ophthalmic Devices
Application:
19/233,240 →
Publication:
US 2025/0298263
Contact Lenses Having Cationic Monomers or Cationic Polymers for Releasing Comfort Agents
Application:
19/297,375 →
Publication:
US 2026/0054913
Contact Lenses Having Cationic Monomers or Cationic Polymers for Releasing Comfort Agents
Application:
19/297,380 →
Publication:
US 2026/0056350
Semifluorinated Alkane Tetracycline Combination Compositions for Treatment of Malar Edema
Application:
19/303,894 →
Publication:
US 2026/0053730
Related Assignments
(24)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 21, 2006
From: GADEK, THOMAS; BURNIER, JOHN
To: SARCODE CORPORATION
Reel/Frame 018155/0742 →
Merger
Oct 25, 2007
From: SARCODE, A CALIFORNIA CORPORATION
To: SARCODE CORPORATION, A DELAWARE CORPORATION
Reel/Frame 020015/0331 →
Correction to Assignee Recorded on Reel 018155 Frame 0742
Dec 5, 2007
From: GADEK, THOMAS; BURNIER, JOHN
To: SARCODE
Reel/Frame 020217/0751 →
Assignment of Assignor's Interest
Oct 15, 2010
From: GADEK, THOMAS; BURNIER, JOHN
To: SARCODE CORPORATION
Reel/Frame 025147/0333 →
Assignment of Assignor's Interest
Oct 15, 2010
From: SHEN, WANG; OSLOB, JOHAN D.; BARR, KENNETH
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 025145/0668 →
Assignment of Assignor's Interest
Oct 22, 2010
From: SUNESIS PHARMACEUTICALS, INC.
To: SARCODE CORPORATION
Reel/Frame 025184/0125 →
Assignment of Assignor's Interest
Mar 29, 2011
From: SUNESIS PHARMACEUTICALS, INC.
To: SARCODE CORPORATION
Reel/Frame 026043/0842 →
Assignment of Assignor's Interest
Mar 29, 2011
From: ZHONG, MIN
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 026043/0509 →
Change of Name
Sep 8, 2011
From: SARCODE CORPORATION
To: SARCODE BIOSCIENCE INC.
Reel/Frame 026876/0312 →
Security Agreement
Feb 8, 2013
From: SARCODE BIOSCIENCE INC.
To: SILICON VALLEY BANK
Reel/Frame 029778/0888 →
Merger
Feb 13, 2013
From: SARCODE, A CALIFORNIA CORPORATION
To: SARCODE CORPORATION, A CORPORATION OF STATE OF DELAWARE
Reel/Frame 029804/0051 →
Release of Security Interest
Apr 25, 2013
From: SILICON VALLEY BANK
To: SARCODE BIOSCIENCE INC.
Reel/Frame 030295/0028 →
Assignment of Assignor's Interest
Apr 16, 2015
From: SHEN, WANG; OSLOB, JOHAN D.; BARR, KENNETH; ZHONG, MIN
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 035427/0378 →
Assignment of Assignor's Interest
Apr 16, 2015
From: SUNESIS PHARMACEUTICALS, INC.
To: SARCODE CORPORATION
Reel/Frame 035427/0590 →
Change of Name
Apr 16, 2015
From: SARCODE CORPORATION
To: SARCODE BIOSCIENCE INC.
Reel/Frame 035443/0884 →
Assignment of Assignor's Interest
Sep 27, 2016
From: SARCODE CORPORATION
To: SARCODE BIOSCIENCE INC.
Reel/Frame 040165/0654 →
Assignment of Assignor's Interest
Oct 31, 2019
From: SARCODE BIOSCIENCE INC.
To: NOVARTIS AG
Reel/Frame 050900/0268 →
Assignment of Assignor's Interest
Oct 22, 2020
From: NOVARTIS AG
To: NOVARTIS PHARMACEUTICALS CORPORATION
Reel/Frame 054134/0708 →
Corrective Assignment to Correct the Assignee Name and Address in Cover Sheet from Sarcode Bioscience Inc, to Sarcode Corporation Previously Recorded at Reel: 027825 Frame: 0955. Assignor(S) Hereby Confirms the Assignment.
Jun 7, 2021
From: GADEK, THOMAS; BURNIER, JOHN
To: SARCODE CORPORATION
Reel/Frame 056497/0031 →
Assignment of Assignor's Interest
Jul 9, 2021
From: NOVARTIS AG
To: NOVARTIS PHARMACEUTICALS CORPORATION
Reel/Frame 056800/0532 →
Assignment of Assignor's Interest
Dec 6, 2023
From: NOVARTIS AG
To: BAUSCH + LOMB IRELAND LIMITED
Reel/Frame 065790/0208 →
Assignment of Assignor's Interest
Dec 6, 2023
From: NOVARTIS PHARMACEUTICALS CORPORATION
To: BAUSCH + LOMB IRELAND LIMITED
Reel/Frame 065789/0853 →
Intellectual Property Security Agreement
Dec 23, 2025
From: BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 074050/0709 →
Intellectual Property Security Agreement
Dec 23, 2025
From: BAUSCH + LOMB IRELAND LIMITED
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 074050/0573 →